1044-96-8 Usage
Uses
Used in Pharmaceutical Industry:
(17R)-17-Hydroxy-13-propyl-18,19-dinorpregn-4-en-20-yn-3-one is used as a potential drug candidate for the development of new medications targeting hormone-related disorders or conditions. Its unique structure and functional groups make it a promising candidate for this application.
Used in Endocrinology Research:
In the field of endocrinology, (17R)-17-Hydroxy-13-propyl-18,19-dinorpregn-4-en-20-yn-3-one is used for research purposes to better understand the mechanisms of hormone-related disorders and to develop targeted treatments.
Used in Reproductive Health:
(17R)-17-Hydroxy-13-propyl-18,19-dinorpregn-4-en-20-yn-3-one is also used in the area of reproductive health, where it may contribute to the development of new therapies for conditions affecting fertility or hormone balance.
Further research and testing are required to fully understand and harness the potential of this chemical compound in these applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1044-96-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,4 and 4 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1044-96:
(6*1)+(5*0)+(4*4)+(3*4)+(2*9)+(1*6)=58
58 % 10 = 8
So 1044-96-8 is a valid CAS Registry Number.
InChI:InChI=1/C22H30O2/c1-3-11-21-12-9-18-17-8-6-16(23)14-15(17)5-7-19(18)20(21)10-13-22(21,24)4-2/h2,14,17-20,24H,3,5-13H2,1H3/t17-,18+,19+,20-,21?,22?/m0/s1
1044-96-8Relevant academic research and scientific papers
Synthesis of gon-4-enes
-
, (2008/06/13)
1. A therapeutic composition having progestational activity comprising as active ingredient a 17-aliphatic carboxylic acid ester of 17α-ethynyl-18-methyl-19-nortestosterone and a pharmaceutical carrier for said compound.
Synthesis of 13-alkyl-gon-4-ones
-
, (2008/06/13)
The preparation of 13-methylgon-4-enes and novel 13-polycarbonalkylgon-4-enes by a new total synthesis is described. 13-Alkylgon-4-enes having progestational, anabolic and androgenic activities are prepared by forming a tetracylic gonane structure unsaturated in the 1,3,5(10),9(11) and 14-positions, selectively reducing in the B- and C-rings, and converting the aromatic A-ring compounds so-produced to gon-4-enes by Birch reduction and hydrolysis.
